Nova Publishers
My Account Nova Publishers Shopping Cart
HomeBooksSeriesJournalsReference CollectionseBooksInformationSalesImprintsFor Authors
  Top » Catalog » Books » Pharmaceutical Sciences » My Account  |  Cart Contents  |  Checkout   
Quick Find
Use keywords to find the product you are looking for.
Advanced Search
What's New? more
_Cancer Research Journal - This journal ceased publication after 4#4 (2010). Back Issues are available.
Shopping Cart more
0 items
Shipping & Returns
Privacy Notice
Conditions of Use
Contact Us
Notifications more
NotificationsNotify me of updates to Beta-Blockers: Physiological, Pharmacological and Therapeutic Implications
Tell A Friend
Tell someone you know about this product.
Beta-Blockers: Physiological, Pharmacological and Therapeutic Implications
Retail Price: $230.00
10% Online Discount
You Pay:

Editors: John R. Richards, M.D. (Department of Emergency Medicine, University of California, Davis School of Medicine, Sacramento, California, USA)
Book Description:
In the late 1950s, Sir James Black made a tremendous contribution to pharmacology and medicine with his discovery of -blockers. After the first -blockers became available in the 1960s, these drugs were noted to have beneficial effects in reducing morbidity and mortality from ischemic heart disease. It soon thereafter became apparent that blocking the adverse effects of the sympathetic nervous system could benefit many other diseases. As research and development continued, later generations of -blockers appeared, each with unique properties such that it is now impossible to group these agents into one class to uniformly describe their effects. In this edition of Beta-Blockers: Physiological, Pharmacological and Therapeutic Implications, the authors examine how -blockers have evolved from their origin as a treatment for angina to a myriad of other related and unrelated medical conditions. These include (in order of appearance), heart failure, hypertension, sepsis, tachydysrhythmias, portal hypertension, variceal bleeding, stimulant toxicity, thyrotoxicosis, obstructive lung disease, trauma, pheochromocytoma, cancer, acute coronary syndromes, and coronary arterial disease. The authors of these chapters hail from a spectrum of medical specialties as diverse as the indications for -blockers: anesthesiology, cardiology, critical care, emergency medicine, gastroenterology, hematology/oncology, internal medicine, pharmacology, pulmonology, surgery, and toxicology. In this book, we also discuss controversies as well as the evolving and changing indications and contraindications for the use of this amazing class of drugs. This book will be of interest to physicians, pharmacists, nurse practitioners, physician assistants, nurses, research scientists, and informed patients. (Nova Biomedical)

Weve partnered with Copyright Clearance Center to make it easy for you to request permissions to reuse Nova content.
For more information, click here or click the "Get Permission" button below to link directly to this book on Copyright Clearance Center's website.

Table of Contents:

Chapter 1. Beta-Blockers for Heart Failure: Pharmacology, Relevance, and Justification (pp. 1-44)
(Shahid Akbar and John R. Richards)

Chapter 2. Beta-Blockers for Control of Hypertension: Controversy, Evidence, and Current Practice (pp. 45-78)
(Shahid Akbar and John R. Richards)

Chapter 3. Beta-Blockers in Critical Care and Obstructive Lung Diseases: New Directions (pp. 79-106)
(Brooks T. Kuhn, E. Pierce Stewart, Mark V. Avdalovic, Timothy E. Albertson and Michael Schivo)

Chapter 4. Beta-Blockers Following Traumatic Injury (pp. 107-120)
(Tyler J. Loftus, Elizabeth S. Miller and Alicia M. Mohr)

Chapter 5. Beta-Blocker Overdose: Progressive Treatment Options (pp. 121-146)
(Timothy. E. Albertson, Alyrene A. Dorey, John R. Richards and Susan Murin)

Chapter 6. Beta-Blockade in Septic Shock: A Paradigm Shift in Management? (pp. 147-166)
(Richard Browne and Tony Whitehouse)

Chapter 7. The Unopposed Alpha-Stimulation Phenomenon: What is the Role of Beta-Blockers? (pp. 167-230)
(John R. Richards, Howard E. McKinney Jr and Bernard Silke)

Chapter 8. Beta-Blockers and Cancer: An Emerging Treatment (pp. 231-262)
(Shahid Akbar and John R. Richards)

Chapter 9. The Use of Beta-Blockers in the Emergency Department (pp. 263-272)
(Max Hockstein and Deborah Diercks)

Chapter 10. Beta-Adrenergic Blockade in Patients with Myocardial Infarction: Evolution, Efficacy and Controversy (pp. 273-286)
(Ezra A. Amsterdam, Shahad Al Chalaby, Sean Fraser, Naveen Gupta, Tina Gupta, Muhammad Majid, Balasingam Thevakumar, Navya Sree Vipparla and Sandhya Venugopal)

Chapter 11. Beta-Blocker Therapy for Acute Coronary Syndrome and Stable Coronary Artery Disease: Current Issues and Outcomes (pp. 287-298)
(Manoj Kesarwani)

About the Editor (pp. 299-300)

Index (pp. 301)

Total Pages: 314

      Pharmacology - Research, Safety Testing and Regulation
   Binding: Hardcover
   Pub. Date: 2018 - March
   ISBN: 978-1-53613-311-0
   Status: AV
Status Code Description
AN Announcing
FM Formatting
PP Page Proofs
FP Final Production
EP Editorial Production
PR At Prepress
AP At Press
AV Available
Special Focus Titles
01.Violent Communication and Bullying in Early Childhood Education
02.Cultural Considerations in Intervention with Women and Children Exposed to Intimate Partner Violence
03.Chronic Disease and Disability: The Pediatric Lung
04.Fruit and Vegetable Consumption and Health: New Research
05.Fire and the Sword: Understanding the Impact and Challenge of Organized Islamism. Volume 2

Nova Science Publishers
© Copyright 2004 - 2021

Beta-Blockers: Physiological, Pharmacological and Therapeutic Implications